| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Wednesday - Nov 26, 2025 |
|||||||||
| Q4 FY25 | $3.93 | $3.84 | $12.09B | $9.83B |
NYSE |
||||
|
Ingles Markets
IMKTA
|
- | $1.35 | - | $1.37B | - |
NASDAQ |
|||
|
Lee Enterprises
LEE
|
Q4 FY25 | -$1.06 | -$0.06 | $139.11M | $153.06M |
NASDAQ |
|||
|
Surmodics
SRDX
|
- | - | -$0.19 | - | $30.14M |
NASDAQ |
|||
|
Protagenic Therapeutics
PTIX
|
- | -$0.47 | - | - | - |
NASDAQ |
|||
